Clinical Trial Update: Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial evaluating Zalutumumab with radiotherapy in head and neck squamous cell carcinoma patients ineligible for platinum-based chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-12-23